Loading...

656: Shareholder Meeting And Dividend Decision Will Drive Positive Momentum

Published
09 Feb 25
Updated
04 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
16.5%
7D
1.6%

Author's Valuation

HK$5.6712.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 04 Nov 25

Fair value Increased 2.27%

Analysts have raised their price target for Fosun International from $5.54 to $5.67, citing updated evaluations of future profitability and expectations for stronger valuation metrics, even though revenue growth and profit margin forecasts are modestly lower. What's in the News A special shareholders meeting is scheduled for October 23, 2025, with a vote on the adoption of the 2025 H share RSU scheme for Fosun Pharma and authorization for directors to implement the plan (Key Developments).

Shared on 21 Oct 25

Fair value Increased 4.42%

Analysts have raised their price target for Fosun International from $5.31 to $5.54, citing modest adjustments in forward valuation metrics as well as updated profitability expectations. What's in the News Fosun International Limited will hold a Special or Extraordinary Shareholders Meeting on October 23, 2025, in Shanghai to seek approval for the adoption of the 2025 H share RSU scheme of Fosun Pharma.

Shared on 01 Sep 25

Fair value Increased 4.76%

Fosun International’s consensus price target has increased to HK$5.30, primarily reflecting stronger expected revenue growth and a considerable improvement in net profit margin. What's in the News Board meeting scheduled to review interim results and consider interim dividend payment for the six months ended 30 June 2025.

Shared on 01 May 25

Fair value Increased 1.91%

Shared on 23 Apr 25

Fair value Decreased 34%

AnalystConsensusTarget has decreased future PE multiple from 9.4x to 6.2x.

Shared on 17 Apr 25

Fair value Decreased 0.53%

AnalystConsensusTarget has increased profit margin from 2.8% to 3.1% and decreased future PE multiple from 10.5x to 9.4x.

Shared on 09 Apr 25

Fair value Increased 0.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 1.78%

AnalystConsensusTarget has increased revenue growth from 5.1% to 8.3%, increased profit margin from 2.3% to 3.0% and decreased future PE multiple from 13.8x to 9.7x.

Shared on 26 Mar 25

Fair value Decreased 1.08%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 57%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 0.16%